New pain drug SBS-1000 takes first step in human safety trial
NCT ID NCT05721287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of a new drug called SBS-1000 in 48 healthy adults to see if it is safe and how the body handles it. Participants were randomly assigned to receive either the drug or a placebo by IV. The main goal was to check for side effects and measure drug levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Kansas
Overland Park, Kansas, 66212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Steroid shot or sports tape: which eases wisdom tooth pain better?
- Simple breathing exercises after gallbladder surgery may cut pain and nausea
- Swiss launch national pain registry to uncover how treatments really work
- Brain scans reveal how imagining acupuncture may rewire pain pathways
- Could a Computer-Controlled needle make dental visits less scary for kids?
- Pain research seeks volunteers for future studies